Skip to main content

Advertisement

Log in

Diffuse skeletal muscle metastases from sacral chordoma

  • Case Report
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Chordomas are rare, slow-growing tumors arising from cellular remnants of the notochord. They account for 1–4 % of primary malignant bone tumors and usually occur in the axial skeleton, most commonly the sacrum. Although typically locally recurrent, chordoma metastasis rates as high as 10–42 % have been reported. While spread to multiple organ systems has been documented, metastatic disease to skeletal muscle is extremely rare. We present a case of extensive, multifocal skeletal muscle metastases developing in the setting of recurrent sacral chordoma. Our literature search found only one additional case of metastatic chordoma to a single skeletal muscle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. McPherson CM, Suki D, McCutcheon IE, Gokaslan ZL, Rhines LD, Mendel E. Metastatic disease from spinal chordoma: a 10-year experience. J Neurosurg Spine. 2006;5(4):277–80.

    Article  PubMed  Google Scholar 

  2. Chambers PW, Schwinn CP. Chordoma. A clinicopathologic study of metastasis Am J Clin Pathol. 1979;72(5):765–76.

    CAS  PubMed  Google Scholar 

  3. Fearon C, Fabre A, Heffernan EJ, Skehan SJ, Swan N, Keane MP, et al. Metastatic chordoma detected by endobronchial ultrasound-guided transbronchial needle aspiration. J Thorac Dis. 2013;5(1):90–3.

    PubMed Central  PubMed  Google Scholar 

  4. Robinson G, Britton J (2005). Sacral chordoma. http://www.eurorad.org/case.php?id=3286 Accessed 21 May 2013

  5. Stacchiotti S, Longhi A, Ferraresi V, Grignani G, Comandone A, Stupp R, et al. Phase II study of imatinib in advanced chordoma. J Clin Oncol. 2012;30(9):914–20.

    Article  CAS  PubMed  Google Scholar 

  6. Farsad K, Kattapuram SV, Sacknoff R, Ono J, Nielsen GP. Sacral chordoma. Radiographics. 2009;29(5):1525–30.

    Article  PubMed  Google Scholar 

  7. Diel J, Ortiz O, Losada RA, Price DB, Hayt MW, Katz DS. The sacrum: pathologic spectrum, multimodality imaging, and subspecialty approach. Radiographics. 2001;21(1):83-104.

    Article  CAS  PubMed  Google Scholar 

  8. Sacral chordoma. https://my.statdx.com/STATdxMain.jsp?rc=false#dxContent;chordoma__spine. Accessed 29 October 2013.

  9. Bethke KP, Neifeld JP, Lawrence Jr W. Diagnosis and management of sacrococcygeal chordoma. J Surg Oncol. 1991;48(4):232–8.

    Article  CAS  PubMed  Google Scholar 

  10. Mukherjee D, Chaichana KL, Gokaslan ZL, Aaronson O, Cheng JS, McGirt MJ. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. J Neurosurg Spine. 2011;14(2):143–50.

    Article  PubMed  Google Scholar 

  11. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88(9):2122–34.

    Article  CAS  PubMed  Google Scholar 

  12. Kilgore S, Prayson RA. Apoptotic and proliferative markers in chordomas: a study of 26 tumors. Ann Diagn Pathol. 2002;6(4):222–8.

    Article  PubMed  Google Scholar 

  13. Mukherjee D, Chaichana KL, Parker SL, Gokaslan ZL, McGirt MJ. Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database. Eur Spine J. 2013;22(6):1375–82.

    Article  PubMed  Google Scholar 

  14. Surov A, Hainz M, Holzhausen HJ, Arnold D, Katzer M, Schmidt J, et al. Skeletal muscle metastases: primary tumours, prevalence, and radiological features. Eur Radiol. 2010;20(3):649–58.

    Article  PubMed  Google Scholar 

  15. Bar-Yehuda S, Barer F, Volfsson L, Fishman P. Resistance of muscle to tumor metastases: a role for A3 adenosine receptor agonists. Neoplasia. 2001;3:125–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Herring Jr CL, Harrelson JM, Scully SP. Metastatic carcinoma to skeletal muscle. A report of 15 patients. Clin Orthop Relat Res. 1998;355:272–81.

    Article  PubMed  Google Scholar 

  17. Park L, Delaney TF, Liebsch NJ, Hornicek FJ, Goldberg S, Mankin H, et al. Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys. 2006;65(5):1514–21.

    Article  PubMed  Google Scholar 

  18. Fourney DR, Rhines LD, Hentschel SJ, Skibber JM, Wolinsky JP, Weber KL, et al. En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine. 2005;3:111–22.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. Jon Dalton, MD, for his assistance with the preparation and review of this manuscript. The authors would also like to thank Kelly Viola, ELS, for her editorial assistance.

Conflict of Interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph Bestic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carey, K., Bestic, J., Attia, S. et al. Diffuse skeletal muscle metastases from sacral chordoma. Skeletal Radiol 43, 985–989 (2014). https://doi.org/10.1007/s00256-013-1794-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-013-1794-1

Keywords

Navigation